|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.99 / 2.71|
Pain Therapeutics Announced today that an FDA Advisory Committee Meeting for REMOXY® is Not Needed and No Change to September 25, 2016 PDUFA Date
FDA's Tentative Date for Advisory Committee Meeting is August 5, 2016 and No Change to PDUFA Date of September 25, 2016
Stocks with insider trader activity include SMLP, DRRX and MDSO
Stocks with insider trader activity include DRRX, EA and KAI
Single-Ascending-Dose Study in NASH Patients
Initial Phase 1 Safety Studies Successfully Completed, Positioning for the Start of Patient Studies in 2016
The most recent short interest data has been released by the NASDAQ for the 07/15/2015 settlement date, which shows a 3,326,063 share increase in total short interest for Durect Corp , to 5,876,167, an increase of 130.43% since 06/30/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Investors in Durect Corp saw new options begin trading this week, for the August 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DRRX options chain for the new August 21st contracts and identified the following call contract of particular interest.